North Run Capital, LP Lensar, Inc. Call Options Transaction History
North Run Capital, LP
- $43 Million
- Q4 2022
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding LNSR
# of Institutions
72Shares Held
5.05MCall Options Held
58.3KPut Options Held
19K-
Brandes Investment Partners, LP La Jolla, CA545KShares$7.38 Million0.08% of portfolio
-
Dimensional Fund Advisors LP Austin, TX478KShares$6.47 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA442KShares$5.99 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny314KShares$4.25 Million0.01% of portfolio
-
Paul Tudor Jones Tudor Investment Corp Et Al | Stamford, Ct277KShares$3.75 Million0.01% of portfolio
About LENSAR, Inc.
- Ticker LNSR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 11,021,000
- Market Cap $149M
- Description
- LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in...